Antitumor effects of ribavirin in combination with TMZ and IFN‑β in malignant glioma cells-Reference-Cited by-同舟云学术

Antitumor effects of ribavirin in combination with TMZ and IFN‑β in malignant glioma cells

Published:2020-08-31 Issue:5 Volume:20 Page:1-1
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Ochiai Yushi¹,Sumi Koichiro¹,Sano Emiko²,Yoshimura Sodai¹,Yamamuro Shun¹,Ogino Akiyoshi¹,Ueda Takuya²,Suzuki Yutaka²,Nakayama Tomohiro³,Hara Hiroyuki⁴,Katayama Yoichi¹,Yoshino Atsuo¹

Affiliation:

1. Department of Neurological Surgery, Nihon University School of Medicine, Tokyo 173‑8610, Japan

2. Department of Computational Biology and Medical Science, Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277‑8562, Japan

3. Division of Companion Diagnostics, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo 173‑8610, Japan

4. Division of Functional Morphology, Department of Functional Morphology, Nihon University School of Medicine, Tokyo 173‑8610, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination Therapy of Temozolomide, Ribavirin and Interferon-Beta for Glioblastoma In Vivo;Journal of Nihon University Medical Association;2023-10-01

2. Glioblastoma as a Novel Drug Repositioning Target: Updated State;Anti-Cancer Agents in Medicinal Chemistry;2023-07

3. A comparative DFT study on Al- and Si- doped single-wall carbon nanotubes (SWCNTs) for Ribavirin drug sensing and detection;Materials Science in Semiconductor Processing;2023-05

4. The dark side of mRNA translation and the translation machinery in glioblastoma;Frontiers in Cell and Developmental Biology;2023-03-13

5. Novel Synergistic Combination of Pamidronate and Temozolomide for Breast Cancer Therapeutics;Current Cancer Drug Targets;2023-03